Driving Stem Cell Research Towards Therapy

Date & time: 
21 May 2012 - 9:00am - 22 May 2012 - 7:00pm

 

 

 

A symposium to honour Sir Ian Wilmut FRS and to mark the opening of the new Scottish Centre for Regenerative Medicine Building.

Speakers include

 

Registration
Register for this event via the University of Edinburgh's e-pay system.

28 February 2012 - early registration discount ends
17 May 2012 - last booking date

Costs

  • £160.00 for employees of higher education or research institutions
  • £250.00 for commercial companies external to public funded bodies
  • £80.00 for registered students of higher education or research institutions
  • Optional gala dinner on the evening of Monday 21st to honour Professor Sir Ian Wilmut, seats priced at £65 per head.
  • Preferential rates available for accommodation, please see the 'More info' tab on the registration site.


Lead sponsors
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com

Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition with innovative life science products and applications. For more information please visit: www.lifetechnologies.com

 

Additional support from

 



 

 

 

 

 

 

 

 

 

 

AttachmentSize
Symposium Driving Stem Cell Research Towards Therapy390.17 KB